ETST Reports Strong FY26 with $1.2M Share Buyback, Debt-Free Growth, and Cash Flow Positive Operations
Summary
Earth Science Tech, Inc. released its annual shareholder letter for FY2026, highlighting over $1.2 million in share repurchases, significant debt-free operational growth, and cash flow positive performance across its health and wellness segment.
Key Events · Corporate Governance and Compliance · ETST
-
Significant Share Repurchases
The company repurchased and retired over 6.9 million shares of common stock since Q1 FY2026, totaling approximately $1.24 million, representing 2.37% of its market capitalization.
-
Debt-Free Operational Growth
Multiple acquisitions and new ventures, including Mister Meds, DOConsultation, Villas Health, and MyOnlineConsultation, were launched and expanded without incurring additional debt, and are now cash flow positive.
-
Strong Segment Performance
Peaks Curative surpassed $2 million in revenue in the first week of Fiscal Q4 2026, contributing to the company's overall cash flow positive operating platform.
-
Positive Future Outlook
Management expressed confidence in continued geographic expansion, potential acquisitions, and the Health/Wellness segment driving most of the revenue in the current fiscal year.
Analysis · ETST · Life Sciences
This 8-K provides a comprehensive positive update on Earth Science Tech's performance, emphasizing a substantial share repurchase program valued at over $1.2 million, representing 2.37% of the company's market capitalization. The letter details successful, debt-free expansion of its health and wellness operations, including acquisitions and new platform launches that are now cash flow positive. These achievements, coupled with a strong outlook and management's confidence, suggest improved financial health and a commitment to shareholder value.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ETST was trading at $0.18 on OTC in the Life Sciences sector, with a market capitalization of approximately $52.2M. The 52-week trading range was $0.00 to $0.24. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.